ASPIRA-aXA
Pseudophakic reliability for you and your patients
The innovative XL optic of the ASPIRA-aXA combines the advantages of a 7.0 mm optic with the stability of the new cut-out haptic design. This posterior-chamber IOL an be conveniently implanted using small-incision technology while adhering to surgical routine.
Overview of topics
Monofocal ASPIRA-aXA
Personal
Contact
Type | Monofocal 1-piece posterior chamber lens, foldable |
Optic diameter | 7.0 mm |
Total diameter | 11.0 mm |
Material | Glistening-free, hydrophilic acrylic, UV blocker |
Optic features | Aspherical anterior surface, aberration-free, 360° LEC barrier |
Haptic design | Cut-out haptics |
Constants for IOL calculation | Please click here |
XL diopter range ASPIRA-aXA | Preloaded SAFELOADER® 10.0 to 30.0 D in 0.5 D steps Compact Line |
XL diopter range ASPIRA-aXAY Yellow | Preloaded SAFELOADER® 10.0 to 30.0 D in 0.5 D steps |
eIFU | ASPIRA-aXA/-aXAY SAFELOADER® |
Injector system | Please click here |
Preloaded implantation system
SIMPLE. INTUITIVE. FAST.
SAFELOADER®
ASPIRA-aXA
MORE THAN A CONVENTIONAL IOL
The XL optic design of the posterior chamber IOL with its extended optic diameter of 7.0 mm
and permits implantation through small incisions at the same time.
ASPIRA-aXA
THE ROUTINE REMAINS
ASPIRA-aXA
PROVIDES THE SOLUTION
ASPIRA-aXA provides a custom solution for the most diverse needs. Possible applications range from standard cataract surgery to refractive surgery and combined interventions in retinal surgery.
ASPIRA-aXA
FULFILLING PATIENT REQUIREMENTS
Advantages of an XL optic
LARGE PUPILS
With its XL optic the ASPIRA-aXA provides an ideal treatment option even under poor lighting conditions.
20% of cataract patients have a scotopic pupil diameter of ≥6 mm. In 10% of patients, even the mesopic pupil is ≥6 mm.
APPROX. 20 %
SCOTOPIC PUPIL DIAMETER ≥6 mm
APPROX. 10 %
MESOPIC PUPIL DIAMETER ≥6 mm
For an untroubled visual outcome
PREVENT PHOTIC PHENOMENA
Simulated beam guidance – 6.0 mm optic
Simulated beam guidance – 7.0 mm optic
Graphic based on a simulation using Optic Studio 16.5, Zemax with a 6 mm optic (1) and a 7 mm optic (2); pupil size – both 6 mm.
ASPIRA-aXA
ELIMINATING DYSPHOTOPSIAS
The ASPIRA-aXA with its enlarged XL optic represents a promising approach to prevent negative dysphotopsia.
UP TO 20% – NEGATIVE DYSPHOTOPSIA
Almost 20% of patients notice negative dysphotopsia after implantation of a standard IOL
UP TO 3% – PERSISTENT
Nearly 3% of pseudophakic patients are severely impaired by negative dysphotopsia permanently
Negative Dysphotopsia
MULTIFACTORIAL ORIGIN
Negative dysphotopsia can occur after successful cataract sugery with IOL implantation. The reasons for development of negative dysphotopsia in pseudophakic eyes seem to be multifactorial. Discussed are among others:
A model
FOR THE DEVELOPMENT OF NEGATIVE DYSPHOTOPSIA
Numerous ray tracing analyses using standard IOLs show a non-illuminated region of the peripheral nasal retina. This “shadow” is caused by the reduced optic diameter and the central thickness of the artificial IOL compared to the natural lens.
Schematic drawing modified according to Holladay
2.5 mm pupil, 6.0 mm IOL
The retinal image is generated by light rays refracted by the IOL optic (areal A), as well as by light rays that hit the retinal periphery (area B) either directly or indirectly refracted by the IOL edge. The unilluminated gap between these two areas can lead to the perception of negative dysphotopsia.
ASPIRA-aXA
CLINICALLY CONVINCING
0% Negative dysphotopsia
100% Patient satisfaction
Outstanding visual results
Pseudophakic reliability
WHAT IS THE ADVANTAGE OF AN XL OPTIC?
RISK
Approx. 20% – diabetes mellitus type 2
Cases in the age group of the average cataract patient
Over 65% – develop diabetic retinopathy
In the group of diagnosed diabetics within 20 years
REASONS
For visual impairment, according to WHO, are mainly
- diabetic retinopathy
- myopia (with the risk of developing high myopia including resulting secondary diseases)
TENDENCY
increasing
PREVENTION
An investment to the future
The panoramic IOL
KEEPING TRANSPARENCY
From a vitreoretinal point of view, both the surgeon and the postoperative doctor benefit from the extended fundus view. The assessment of the posterior segment of the eye and the implementation of therapeutic measures for peripheral retinal diseases can occur more conveniently.
ASPIRA-aXA offers patients with an increased risk of ocular diseases an advantage for long-term, successful pseudophakic treatment.
FOR AN EXCELLENT
INTRAOPERATIVE VIEW
Intraoperative fundus image* (1) Edge of the XL optic (2) Theoretical optic edge of a 6.0 mm IOL
Intraoperative image with implanted ASPIRA-aXA** (1) Edge of the XL optic (2) Rhexis: diameter 6.0 mm
FOR AN CONVENIENT
POSTOPERATIVE FOLLOW-UP
* Courtesy of Univ.-Prof. Dr. M. Bolz, Linz
** Courtesy of Prof. Dr. G. Duncker, Halle
The panoramic IOL
EXPERTS RECOMMEND
Prof. W. Sekundo, Marburg
“The large ASPIRA-aXA optic has proven itself in phaco-vitrectomies because it allows an edge-free view into the outer retinal periphery.”
Personal Statement, 2018
Univ.-Prof. Dr. Matthias Bolz, MD, Linz
„The view into the periphery is not only important for standard funduscopy, but also for diagnostics, fluorescence angiography and above all for retinal surgery.”
Die ASPIRA-aXA aus Sicht eines Retinologen. Presentation DOC (Internationaler Kongress der Deutschen Ophthalmochirurgen), HumanOptics Booth Lecture, Nuremberg, 2018.
Y. Takamura, MD, PhD.
“The creation of a larger capsulorhexis with implantation of a 7.0 mm optic IOL contributed to a larger anterior capsule opening after cataract surgery in patients with DM [diabetes mellitus].”
Takamura, Y., et al. Large capsulorhexis with implantation of a 7,0 mm optic lens during cataract surgery in patients with diabetes mellitus. J Catract Refract Surg 2014; 40(11):1850-1856.
Outstanding material meets best-in-class technology
A MATERIAL TO WIN YOU OVER
High transmission. High quality.
High Abbe number. High contrast sensitivity.*
A high Abbe number, as a quality measure of the imaging properties of IOLs, is associated with
* Zhao, H., Mainster, M. (2007). The effect of chromatic dispersion on pseudophakic optical performance. Br J Ophthalmol. 91 (9):1225-1229.
Easy application
SAFE POSITIONING
Dr. J. Schrecker, Glauchau
„Implantation can be performed with the same incision width as with a standard IOL.”
Personal statement, 2018
PROVEN TO BE ROTATIONALLY STABLE
Choose
– AS DESIRED.
7.0 mm optic – preloaded
SAFELOADER®
SIMPLE. INTUITIVE. FAST.
The contactless preloaded implantation system offers a maximum of safety combined with its intuitive, easy handling.
Click here to see the application video
Reports from clinical application
The space-saving model
COMPACT LINE
For space-saving storage even when space is at a premium – ideal for use in the inpatient sector
Premium IOL ASPIRA-aXA
Your advantages of the premium IOL platform
Clinical performance
What do the experts say?
Dr. E. Becker/ M. Bonsemeyer, Oranienburg
“The ASPIRA-aXA with its enlarged XL optic represents a promising approach to minimize dysphotopsia.”
Piskula, M. Becker, E. (2018). Reduzierte pseudophake Dysphotopsien durch vergrößerte IOL-Optik. Presentation DGII 2018.
Prof. G. Duncker, Halle
“The patient response has been overwhelmingly positive.”
Personal Statement, 2018
Application
Publications
Reports from clinical application
Pilger D., Bertelmann E., Brockmann T, et al.
Postoperative Lens Rotation of a 7.0 mm Optic IOL with Plate Haptics
Int J Ophthal Vision Res. 2021 Dec 07;5(1): 014-020.
Language: English
Borkenstein AF, Borkenstein EM
Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology
Ophthalmol Ther. 2021 Nov 27.doi: 10.1007/s40123-021-00433-3. Epub 2021 Nov 27.
Language: English
Schrecker J, Seitz B, Langenbucher A
[Performance of a new 7 mm intraocular lens with follow-up over 1.5 years]
Ophthalmologe. 2021 Oct 5.doi: 10.1007/s00347-021-01504-3. Online ahead of print.
Language: German
Bonsemeyer MK, Becker E, Liekfeld A
Dysphotopsiae and functional quality of vision after implantation of an intraocular lens with a 7.0 mm optic and plate haptic design
J Cataract Refract Surg. 2021 Jun 28.doi: 10.1097/j.jcrs.0000000000000735. Online ahead of print.
Language: English
Wendelstein J, Laubichler P, Fischinger I, et al.
Rotational Stability, Tilt and Decentration of a New IOl with a 7.0 mm Optic
Current Eye Research 2021 Jun;14
Click here for full report
Language: English
Borkenstein A. F., Borkenstein E. M.
Creating Hybrid Monovision with 7.0 mm XL Optic and High-Add AMD Intraocular Lenses (XL-MAGS) in a Patient with Retinitis Pigmentosa
Case Rep Ophthalmol 2019;10:304-311; doi: 10.1159/000503093
Click here for full report
Language: English
ASPIRA-aXA
Media reports
This post is also available in: German
OUR
CUSTOMER SERVICE
YOUR
QUESTIONS
Our experts support you with your questions at any time.